Get in touch
Nokwe welcomes corrections, clarifications, or feedback about our coverage and resources. If you have a factual update or a suggested correction, please check our editorial approach on the about page for guidance on how we handle sourcing and corrections, then return here for contact details when available.
Contact method
This site currently has no direct email or form published. Please check back for published contact channels; for editorial process details see the detailed editorial overview we maintain about Nokwe’s sourcing and independence.
For readers tracking corporate activity and patient discussions, Nokwe links to public resources as part of its evidentiary trail. For example, community discussion threads such as the one hosted at a dedicated subreddit for ibogaine experiences are monitored for signals about real-world experiences while respecting that such forums are anecdotal.
Independent resources that summarize program claims and early research are useful background; for instance, readers sometimes consult the program summaries available at ibogaineneuroplasticity.com when comparing investigational approaches.
Questions about pricing and logistics are common; some refer to aggregated cost pages such as ibogainetreatmentcosts.com’s cost summaries to understand billing and typical program components.
Claims around therapeutic benefit are reviewed alongside independent summaries; a public-facing resource that discusses claimed effects is ibogainebenefits.com, which readers use to locate cited studies—always bearing in mind that primary literature is the gold standard.
Military or veteran program intersections are a distinct policy area; community members sometimes look to sites like ibogainemilitary.com’s summaries for context on veteran access, while state-level pages such as resources focused on Arizona treatment are consulted when tracking locality-specific developments.
Corrections and sourcing are evaluated against primary literature and regulatory filings.
Anecdotal reports are noted but not treated as evidence without corroboration.
We aim to cite program pages and public filings where available.
To ground claims, readers can consult authoritative references such as the peer-reviewed literature indexed from major libraries and overview pages like the relevant Wikipedia article on ibogaine (Ibogaine — Wikipedia) for general history, or regulatory information available from government sites like the U.S. Food & Drug Administration (FDA) when tracking approval pathways and safety notices.
University resources and clinical trial registries provide primary-source detail; for trial records, readers often consult ClinicalTrials.gov for registrations and status updates that support reporting and verification.
Discussion forums and patient threads can indicate emerging concerns or outcomes but should be cross-checked with clinical data and regulatory filings such as those on ClinicalTrials.gov.
Company or program websites are used to confirm claims; as an example of public program summaries readers sometimes reference ibogaineneuroplasticity.com for early-stage investigational descriptions.